These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5940860)

  • 41. Non-specific effect of measles vaccination on all-cause child mortality: revisited.
    Kabir Z; Aaby P
    Indian Pediatr; 2005 Jun; 42(6):541-4. PubMed ID: 15995270
    [No Abstract]   [Full Text] [Related]  

  • 42. Vaccination against measles.
    Br Med J; 1966 Feb; 1(5485):435-6. PubMed ID: 5902677
    [No Abstract]   [Full Text] [Related]  

  • 43. [The anti-measles vaccination].
    Marchand JC
    Cah Med; 1970 Nov; 11(13):1105-8. PubMed ID: 5502818
    [No Abstract]   [Full Text] [Related]  

  • 44. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bioelectrical brain activity of children in measles and in immunization with live measles vaccine].
    Askerov VF; Mirozian NS
    Vopr Okhr Materin Det; 1969 May; 14(5):87-8. PubMed ID: 5349913
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical aspects of the vaccination campaign with a dose of 500 TCD-50 of live attenuated measles vaccine in the Materno-Infantile Clinic of "La Palmilla" District, Northern Hospital District of Santiago. National Health Service. (Preliminary report)].
    Villarroel L; Oyarce P; Monreal R; Roman N; Canelo J; Palaneck K; Vildosola C
    Pediatria (Santiago); 1965; 8(2):121-6. PubMed ID: 5842687
    [No Abstract]   [Full Text] [Related]  

  • 49. [Results of the 1968 measles vaccination campaign].
    Gimeno de Sande A; Nájera R; Nájera E; Ortíz Berrocal A; Pérez Gallardo F
    Rev Sanid Hig Publica (Madr); 1972 Sep; 46(9):805-21. PubMed ID: 4668448
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effectiveness of the use of live measles vaccine (LMV) in the Ukrainian SSR].
    Zelinskiĭ AN; Siniak KM
    Vrach Delo; 1974 Feb; (2):1-6. PubMed ID: 4468597
    [No Abstract]   [Full Text] [Related]  

  • 51. [Anti-measles vaccination with inactivated virus].
    Terragna A; Roscioli B; De Marco B
    G Mal Infett Parassit; 1967 Apr; 19(4):219-22. PubMed ID: 5614197
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients.
    Pauksen K; Linde A; Lönnerholm G; Ljungman P; Sjölin J
    Bone Marrow Transplant; 1996 Nov; 18(5):969-73. PubMed ID: 8932853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Protective effect of measles vaccine in nursery schools and kindergartens].
    Plesník V; Landtová J
    Cesk Pediatr; 1972 Mar; 27(3):135-7. PubMed ID: 5026347
    [No Abstract]   [Full Text] [Related]  

  • 54. [On vaccination against measles with a live and attenuated virus (Schwarz strain) in a nursery school. Resistance to natural infection (author's transl)].
    Nardi G; Battistini A; Mazzeo G; Tanzi ML; Grzincich GL
    Ann Sclavo; 1977; 19(6):1144-52. PubMed ID: 618060
    [No Abstract]   [Full Text] [Related]  

  • 55. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Results of the use of the Leningrad-4 live measles vaccine during increasing measles morbidity].
    Revenok ND; Smorodintsev AA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():361-71. PubMed ID: 5860954
    [No Abstract]   [Full Text] [Related]  

  • 57. [Is vaccination against measles justified?].
    Lerche C
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2435-8. PubMed ID: 4657021
    [No Abstract]   [Full Text] [Related]  

  • 58. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measles vaccine efficacy evaluated by case reference technique.
    Puri A; Gupta VK; Chakravarti A; Mehra M
    Indian Pediatr; 2002 Jun; 39(6):556-60. PubMed ID: 12084949
    [No Abstract]   [Full Text] [Related]  

  • 60. Optimal age for vaccinating Zimbabwean children against measles. 1. Maternal and transplacentally transmitted measles antibodies in infancy.
    Mhere OT; Mhlanga GE; Spencer HR
    Cent Afr J Med; 1984 Oct; 30(10):187-9. PubMed ID: 6518490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.